Ferric carboxymaltose corrects iron deficiency anemia in advanced cirrhosis

Ferric carboxymaltose corrects iron deficiency anemia in advanced cirrhosis

Intravenous ferric carboxymaltose corrected iron deficiency anemia among patients with advanced cirrhosis, according to a late breaking presentation at the International Liver Congress.“Iron deficiency anemia (IDA) commonly occurs in up to 40% of patients with cirrhosis due to chronic blood loss from gastroesophageal varices and portal gastropathy. Previous studies have suggested anemia in cirrhosis associated with higher occurrence of hepatic decompensation and mortality,” Ilias Tsiakas, University of Ioannina, Ioannina, Greece, said. “The optimal treatment of IDA inRead More

Share on facebook
Share on twitter
Share on linkedin